Table 2.
NCI-CTC grade of adverse reactions during and after GEMFP
| Case | Leukocyte count (pre/end, /μL) | Neutrophil count (pre/end, /μL) | Hemoglobin (pre/end, g/dL) | Platelet count (pre/end, × 104) | Nausea | Anorexia |
| 1 | 3 (5050/1670) | 3 (3232/835) | 0 (14.6/11.8) | 4 (7.5/1.5) | 0 | 1 |
| 2 | 4 (7260/640) | 4 (5520/420) | 4 (15.7/6.2) | 4 (14.8/1.8) | 0 | 0 |
| 3 | 3 (3950/1720) | 3 (2489/774) | 0 (14.0/12.0) | 4 (6.9/1.7) | 0 | 0 |
| 4 | 3 (7950/1430) | 4 (5168/352) | 0 (16.1/11.7) | 4 (20.7/2.0) | 0 | 0 |
| 5 | 3 (3990/1700) | 3 (2993/840) | 0 (14.6/11.3) | 3 (9.6/4.0) | 1 | 0 |
| 6 | 3 (3840/1040) | 4 (2380/357) | 2 (15.2/8.5) | 4 (15.3/0.5) | 0 | 1 |
| 7 | 3 (6790/1950) | 4 (3870/468) | 2 (12.4/9.6) | 2 (13.9/6.4) | 0 | 0 |